miR-21 facilitates CRC progression by repressing PTEN post-transcriptionally, promoting cell growth and invasion; anti-miR-21 strategies have been shown to restore PTEN levels and mitigate malignancy [56]. Here, PTEN is linked to colorectal carcinoma.